Efficacy, Safety and Tolerability of Co-artemether in Non-immune Travelers

Clinical trial NCT00233337 · COMPLETED

Trial details

NCT number: NCT00233337
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Acute Uncomplicated P. Falciparum Malaria

Start date: 2001-05-01
Primary completion: 2005-08-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.